Novoprotein Scientific Inc. (SHSE: 688137)
Health Care · Biotechnology · CN
CN¥161.18
+0.49% today · +284.7% 1Y
Novoprotein Scientific Inc. (SHSE: 688137) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.67B.
Over the last twelve months the share price has gained 284.7%, trading between 33.20 and 168.03.
Tweenvest scores Novoprotein Scientific Inc. across four factors: quality 59/100, value 65/100, growth 0/100. Its strongest factor is value.
688137 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.67B
- Revenue (TTM)
- $22.50M
- P/E
- —
- EPS
- -1.18
- Dividend yield
- —
- Beta (5Y)
- 1.27
- 52-week high
- CN¥168.03
- 52-week low
- CN¥33.20
- Avg volume (3M)
- —
- Shares outstanding
- 69.51M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Absci CorporationNasdaqGS: ABSI | $1.74B | $9.60 | -5.51% |
| Yantai Dongcheng Pharmaceutical Group Co.,Ltd.SZSE: 002675 | $1.71B | CN¥13.89 | +7.67% |
| Freenome, Inc.NasdaqCM: FRNM | $1.70B | $15.78 | -3.31% |
| PYC Therapeutics LimitedASX: PYC | $1.68B | AU$2.45 | -0.41% |
| COMPASS Pathways plcNasdaqGS: CMPS | $1.66B | $11.63 | -3.13% |
| Stoke Therapeutics, Inc.NasdaqGS: STOK | $1.60B | $24.29 | -1.84% |
| Mabwell (Shanghai) Bioscience Co., Ltd.SHSE: 688062 | $1.60B | CN¥24.78 | -8.36% |
| uniQure N.V.NasdaqGS: QURE | $1.57B | $21.64 | -4.21% |
Figures last refreshed Oct 11, 2026.